Market Cap

Taiwan Advance Bio-Pharmaceutical, Inc. Market Capitalization:

TW$1.44 Billion

TWD as of Jan. 1, 2024

US$47.1 Million

business Taiwan Advance Bio-Pharmaceutical, Inc. Company Profile

Taiwan Advance Bio-Pharmaceutical, Inc. Main Stock Listing

TWSE: 4186

Market Capitalization History of Taiwan Advance Bio-Pharmaceutical, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Taiwan Advance Bio-Pharmaceutical, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 TW$1.44 B -12.30%
Jan. 1, 2023 TW$1.65 B -4.89%
Jan. 1, 2022 TW$1.73 B -16.36%
Jan. 1, 2021 TW$2.07 B 15.55%
Jan. 1, 2020 TW$1.79 B -6.07%
Jan. 1, 2019 TW$1.91 B -2.27%
Jan. 1, 2018 TW$1.95 B -16.13%
Jan. 1, 2017 TW$2.33 B -33.38%
Jan. 1, 2015 TW$3.49 B -32.55%
Jan. 1, 2014 TW$5.18 B -10.69%
Jan. 1, 2013 TW$5.80 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Taiwan Advance Bio-Pharmaceutical, Inc. Categories

Taiwan languages Healthcare languages Biotechnology
Taiwan Healthcare Taiwan Biotechnology

Stocks & Indices

Taiwan Advance Bio-Pharmaceutical, Inc. has the following listings and related stock indices.


Stock: TWSE: 4186

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.